Report Detail
Global (United States, European Union and China) Crohn’s Disease Drugs Market Research Report 2019-2025
- RnM3664539 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Crohn’s disease (CD) is a form of inflammatory bowel disease (IBD), which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn’s disease (CD) and ulcerative colitis (UC). The pathophysiology of CD is complex, as the disease is characterized by recurring flares that evolve along with periods of inactivity and remission.
In 2019, the market size of Crohn’s Disease Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Crohn’s Disease Drugs.
This report studies the global market size of Crohn’s Disease Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Crohn’s Disease Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer AG
Amgen
Takeda Pharmaceutical
AbbVie
UCB
Ferring
Eli Lilly
Hoffman-La Roche
Bristol-Myers Squibb
Pfizer
Market Segment by Product Type
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others
Market Segment by Application
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Crohn’s Disease Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Crohn’s Disease Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Crohn’s Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Crohn’s Disease Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Anti-Inflammatory
- 1.3.3 Immune system suppressors
- 1.3.4 Antibiotics
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Crohn’s Disease Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Hospitalshospital Pharmacies
- 1.4.5 Retail Pharmacies
- 1.4.6 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Crohn’s Disease Drugs Market Size
- 2.1.1 Global Crohn’s Disease Drugs Revenue 2014-2025
- 2.1.2 Global Crohn’s Disease Drugs Sales 2014-2025
- 2.2 Crohn’s Disease Drugs Growth Rate by Regions
- 2.2.1 Global Crohn’s Disease Drugs Sales by Regions 2014-2019
- 2.2.2 Global Crohn’s Disease Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Crohn’s Disease Drugs Sales by Manufacturers
- 3.1.1 Crohn’s Disease Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Crohn’s Disease Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Crohn’s Disease Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Crohn’s Disease Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Crohn’s Disease Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Crohn’s Disease Drugs Price by Manufacturers
- 3.4 Key Manufacturers Crohn’s Disease Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Crohn’s Disease Drugs Market
- 3.6 Key Manufacturers Crohn’s Disease Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Anti-Inflammatory Sales and Revenue (2014-2019)
- 4.1.2 Immune system suppressors Sales and Revenue (2014-2019)
- 4.1.3 Antibiotics Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Crohn’s Disease Drugs Sales Market Share by Type
- 4.3 Global Crohn’s Disease Drugs Revenue Market Share by Type
- 4.4 Crohn’s Disease Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Crohn’s Disease Drugs Sales by Application
6 United States
- 6.1 United States Crohn’s Disease Drugs Breakdown Data by Company
- 6.2 United States Crohn’s Disease Drugs Breakdown Data by Type
- 6.3 United States Crohn’s Disease Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Crohn’s Disease Drugs Breakdown Data by Company
- 7.2 European Union Crohn’s Disease Drugs Breakdown Data by Type
- 7.3 European Union Crohn’s Disease Drugs Breakdown Data by Application
8 China
- 8.1 China Crohn’s Disease Drugs Breakdown Data by Company
- 8.2 China Crohn’s Disease Drugs Breakdown Data by Type
- 8.3 China Crohn’s Disease Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Crohn’s Disease Drugs Breakdown Data by Company
- 9.2 Rest of World Crohn’s Disease Drugs Breakdown Data by Type
- 9.3 Rest of World Crohn’s Disease Drugs Breakdown Data by Application
- 9.4 Rest of World Crohn’s Disease Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Crohn’s Disease Drugs Sales by Countries
- 9.4.2 Rest of World Crohn’s Disease Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bayer AG
- 10.1.1 Bayer AG Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.1.4 Crohn’s Disease Drugs Product Introduction
- 10.1.5 Bayer AG Recent Development
- 10.2 Amgen
- 10.2.1 Amgen Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.2.4 Crohn’s Disease Drugs Product Introduction
- 10.2.5 Amgen Recent Development
- 10.3 Takeda Pharmaceutical
- 10.3.1 Takeda Pharmaceutical Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.3.4 Crohn’s Disease Drugs Product Introduction
- 10.3.5 Takeda Pharmaceutical Recent Development
- 10.4 AbbVie
- 10.4.1 AbbVie Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.4.4 Crohn’s Disease Drugs Product Introduction
- 10.4.5 AbbVie Recent Development
- 10.5 UCB
- 10.5.1 UCB Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.5.4 Crohn’s Disease Drugs Product Introduction
- 10.5.5 UCB Recent Development
- 10.6 Ferring
- 10.6.1 Ferring Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.6.4 Crohn’s Disease Drugs Product Introduction
- 10.6.5 Ferring Recent Development
- 10.7 Eli Lilly
- 10.7.1 Eli Lilly Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.7.4 Crohn’s Disease Drugs Product Introduction
- 10.7.5 Eli Lilly Recent Development
- 10.8 Hoffman-La Roche
- 10.8.1 Hoffman-La Roche Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.8.4 Crohn’s Disease Drugs Product Introduction
- 10.8.5 Hoffman-La Roche Recent Development
- 10.9 Bristol-Myers Squibb
- 10.9.1 Bristol-Myers Squibb Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.9.4 Crohn’s Disease Drugs Product Introduction
- 10.9.5 Bristol-Myers Squibb Recent Development
- 10.10 Pfizer
- 10.10.1 Pfizer Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Crohn’s Disease Drugs
- 10.10.4 Crohn’s Disease Drugs Product Introduction
- 10.10.5 Pfizer Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Crohn’s Disease Drugs Sales Channels
- 11.2.2 Crohn’s Disease Drugs Distributors
- 11.3 Crohn’s Disease Drugs Customers
12 Market Forecast
- 12.1 Global Crohn’s Disease Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Crohn’s Disease Drugs Sales Forecast by Type
- 12.3 Global Crohn’s Disease Drugs Sales Forecast by Application
- 12.4 Crohn’s Disease Drugs Forecast by Regions
- 12.4.1 Global Crohn’s Disease Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Crohn’s Disease Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Crohn’s Disease Drugs. Industry analysis & Market Report on Crohn’s Disease Drugs is a syndicated market report, published as Global (United States, European Union and China) Crohn’s Disease Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Crohn’s Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
